HIV-1耐药检测技术进展

Advances in HIV-1 resistance detection technology

  • 摘要: 艾滋病病毒已在全球肆虐40多年,对全球公共卫生造成极大压力,时至今日艾滋病仍然是全球公共卫生面临的一道医学难题。高效联合抗病毒疗法(HAART)是艾滋病治疗的首选方案,已为众多艾滋病患者/人类免疫缺陷病毒(HIV)感染者带来巨大福祉,并为减缓艾滋病病毒的进一步传播发挥了很大作用。但随着这一方案的全面推广与应用,HIV-1耐药性也日益突出。HIV-1耐药性是影响临床抗病毒治疗效果的主要原因之一,因此进行HIV-1耐药性检测,对抗病毒药物的优化与选择、降低传播性耐药发生与防控十分重要。HIV-1耐药检测方法众多,因应用场景不同而方法各异,本文汇总国内外众多文献资料,就HIV-1耐药检测方法进行综述。

     

    Abstract: HIV has ravaged the world for more than forty years, causing great pressure on global public health. Today, AIDS is still a medical challenge for global public health. Highly active anti-retroviral therapy (HAART) is the preferred option for AIDS treatment. It has brought well-being to many people living with HIV, and has played a great role in slowing the further spread of HIV. However, with the comprehensive application of this therapy program, HIV-1 drug resistance has also become increasingly prominent. HIV-1 drug resistance is one of the main causes affecting the efficacy of clinical antiviral therapy. Therefore, it is very important to carry out HIV- 1 drug resistance testing, optimize and select antiviral drugs, reduce the occurrence of transmitted resistance, and prevent and control them. HIV-1 resistance testing methods are numerous and various depending on the application scenarios. This paper summarizes many literatures around the world and comprehensively discusses HIV-1 drug resistance testing methods.

     

/

返回文章
返回